secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2024-06-20T23:59:59+00:00
Accession:  0001683168-24-004361
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 3.02, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis raises $4.3M in Series A Preferred financing; CEO granted 2.4M options
------------------------------------------------------------------------------

- Raised $4.3M via sale of 4,300 shares of Series A Preferred at $1,000/share to accredited investors.
- Financing led by CJC Investment Trust (entity of board member Christopher Calise).
- Series A convertible at $0.40/share; automatic conversion upon $20M+ fundraising.
- CEO David Mehalick granted options for 2.4M shares (fully vested, 10-year term) on June 13.
- Investors also received 6.45% non-voting equity in new subsidiaries SNAP Biosciences and GEAR Therapeutics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316824004361/0001683168-24-004361-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316824004361/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004361

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer